Dequalinium chloride

BNF:: not listed
Status:: Grey
Decision Date:: December 2016

Comments

GREY: For the treatment of recurrent bacterial vaginosis, as a second line option after treatment failure and or intolerance to metronidazole.

Brown Drug Classifications

1: Lack of data on effectiveness compared with standard therapy
5: Less cost-effective than current standard therapy